Error: Could not add to watchlist. X

ARIAD Pharmaceuticals Inc

+ Watchlist
ARIA:US
NASDAQ GS
7.93
USD
0.36
4.76%
As of 14:39:23 ET on 09/04/2015.
Open
7.61
Day Range
7.58 - 8.23
Volume
6,635,097
Previous Close
7.57
52Wk Range
4.90 - 10.07
1 Yr Return
29.15%
Open
7.61
Day Range
7.58 - 8.23
Volume
6,635,097
Previous Close
7.57
52Wk Range
4.90 - 10.07
1 Yr Return
29.15%
YTD Return
15.43%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.89
Market Cap (b USD)
1.500
Shares Outstanding (m)
188.896
Price/Sales (TTM)
11.05
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

Profile
ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.
ADDRESS
26 Landsdowne Street
Cambridge, MA 02139-4234
United States
PHONE
1-617-494-0400
  • Harvey J Berger
    Chairman/President/CEO
  • Timothy P Clackson
    Chief Scientific Ofcr/Pres:R&D
  • Edward M Fitzgerald
    Exec VP/CFO/Treasurer
  • Martin J Duvall "Marty"
    Exec VP/Chief Commercial Ofcr
  • Thomas J Desrosier "Tom"
    Exec VP/Chief Legal Officer
Show More